Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gupta

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Viral Hepatitis|October 31, 2013
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trialC Pande, S K Sarin, S Patra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignanciesR S DiPaola, M M Rafi, V Vyas, et al.
Anti-Cancer Drugs|June 23, 1999
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerC F Verschraegen, E Gupta, E Loyer, et al.
Cancer Research|December 4, 2001
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291J G Naglich, M Jure-Kunkel, E Gupta, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 8, 2006
Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesityLauren N Bell, Jennifer L Ward, Mikako Degawa-Yamauchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxelM Hidalgo, C Aylesworth, L A Hammond, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Viral Hepatitis|October 31, 2013
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trialC Pande, S K Sarin, S Patra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignanciesR S DiPaola, M M Rafi, V Vyas, et al.
Anti-Cancer Drugs|June 23, 1999
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerC F Verschraegen, E Gupta, E Loyer, et al.
Cancer Research|December 4, 2001
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291J G Naglich, M Jure-Kunkel, E Gupta, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 8, 2006
Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesityLauren N Bell, Jennifer L Ward, Mikako Degawa-Yamauchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxelM Hidalgo, C Aylesworth, L A Hammond, et al.
Pageof 6